About CNSThe Center for Neurologic Study Website is designed
to present our current activities on the Internet. CNS is a non profit
organization dedicated to research and treatment of neurological diseases.
The Center was founded in 1979 with the intent of helping patients and
families who have been affected by presently incurable neurologic disease.
To accomplish this, the Center focused on experimental treatment and patient/family
support and education. Along with others CNS was instrumental in the development
of Interferon as a treatment modality. Over the years, the CNS has collaborated
with Biotech companies in an effort to develop cutting edge therapies
for neurologic disorders, including the use of ciliary neurotrophic and
brain derived neurotrophic factors, superoxide dismutase, protropin, T
cell peptide and so forth. The seminal discovery of DMQ at CNS has resulted
in the award of 5 U.S. Patents. This drug combination is under development
for the treatment of emotionality and chronic pain, in part, supported by
a grant from the National Institute of Health.
Our website is the latest in a long
standing effort to provide patient/family education and support.
Beginning in 1979, CNS sponsored one of the first neurologic-based
educational programs. This effort continues in the belief
that information is as important to patient well being as
nutrition and medication. For a number of reasons,
it is our hope to disseminate all of our educational materials
via the web but a hard copy can be sent for those who need
it. At some point, we anticipate being able to bring
our support group & lectures into peoples living rooms, possibly
in an interactive mode. But for the moment it is necessary
to visit us in person or order a video. Soon we will
attempt to place our videos on the internet. A test
run is in the works.
It is our hope that you will join our virtual
community, partnering with us to advance the cause of neurologic research
and treatment.
The Center for Neurologic
Study
© 2002 All rights reserved.
Comments about the site? Let us know.
|